Results 181 to 190 of about 26,315,175 (213)

Modeling acquired TKI resistance and effective combination therapeutic strategies in murine RET+ lung adenocarcinoma. [PDF]

open access: yesCancer Lett
Hinz TK   +11 more
europepmc   +1 more source

Histone deacetylase inhibitors as venetoclax‐sensitising partners in acute myeloid leukaemia: Mechanisms, pharmacology and translational perspectives

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 21, Page 6261-6290, November 2026.
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley   +1 more source

Molecular glue that stabilizes the LRPPRC-MET-G4 interaction complex to drive MET downregulation. [PDF]

open access: yesNat Commun
Li YP   +16 more
europepmc   +1 more source

Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome them. [PDF]

open access: yesCancer Drug Resist
Pagano Mariano M   +8 more
europepmc   +1 more source

Immunological effects of amivantamab in EGFR or MET-expressing non-small cell lung cancer. [PDF]

open access: yesCancer Immunol Immunother
Yoshichika R   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy